Professional Background:
Dr Maggie Aulsebrook is the Head of Radiochemistry at Monash Biomedical Imaging. Maggie has worked in Europe, the United States and Australia with extensive experience in FDA and TGA licensed environments for the supply of sterile radiopharmaceuticals in the private and public health sectors. Maggie holds a PhD in chemistry and has authored multiple peer-reviewed publications in leading scientific journals.
Research Interests:
Dr Aulsebrookâs research focuses on the development and clinical translation of novel radiopharmaceuticals in regulated environments. New technologies of interest include those which utilise new biological targets and non-routine radionuclides. New and improved tools for the diagnosis and treatment of debilitating diseases is crucial to ensure a greater level of patient care.
